| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/03/1995 | WO1995020394A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 08/03/1995 | WO1995020393A1 Use of mometasone furoate for treating airway passage and lung diseases |
| 08/03/1995 | WO1995020392A1 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14α,17α-ETHANOESTRA-1,3,5(10)-TRIENE-3,17β-DIOL |
| 08/03/1995 | WO1995020391A1 Prostacyclin-containing oleaginous ointment |
| 08/03/1995 | WO1995020390A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation |
| 08/03/1995 | WO1995020384A1 Pharmaceutical compositions containing hiv protease inhibitors |
| 08/03/1995 | WO1995020383A1 Modified-release metronidazole compositions and methods for making and using same |
| 08/03/1995 | WO1995020382A1 Process for producing s(+)-ibuprofen particles |
| 08/03/1995 | WO1995020380A1 Intraorally soluble compressed molding and process for producing the same |
| 08/03/1995 | WO1995020378A1 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker |
| 08/03/1995 | WO1995020377A1 Rapidly dissolving oral dosage form |
| 08/03/1995 | WO1995020320A1 Self-assembling multimeric nucleic acid constructs |
| 08/03/1995 | WO1995016430A3 Cosmetic and/or pharmaceutical preparations |
| 08/03/1995 | DE4402379A1 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung Oral dosage form having acidic active ingredients, and processes for their preparation |
| 08/03/1995 | CA2540258A1 Pharmaceutical compositions containing hiv protease inhibitors |
| 08/03/1995 | CA2181907A1 Pharmaceutical compositions comprising hirudin |
| 08/03/1995 | CA2181252A1 Phenylboronic acid complexes |
| 08/03/1995 | CA2179715A1 Use of vanadium molybdenum or tungsten complexes for controlling cellular proliferation |
| 08/03/1995 | CA2159224A1 Prostacyclin-containing oleaginous ointment |
| 08/02/1995 | EP0665020A2 Method for preparing thioether conjugates |
| 08/02/1995 | EP0665019A1 Stable dry powders containing hirudin |
| 08/02/1995 | EP0665010A1 Method of manufacturing wax matrices |
| 08/02/1995 | EP0664834A1 Recombinant humanized anti-cytomegalovirus antibodies |
| 08/02/1995 | EP0664713A1 Therapeutic and diagnostic imaging compositions and methods |
| 08/02/1995 | EP0664710A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
| 08/02/1995 | EP0664697A1 Ranitidine chewable tablets |
| 08/02/1995 | EP0664696A1 Sustained release compositions for treating periodontal disease. |
| 08/02/1995 | EP0550615B1 Drug delivery vehicles suspended in nonaqueous perfluorinated carrier |
| 08/02/1995 | EP0506774B1 Smoking substitute |
| 08/02/1995 | EP0474833B1 Stable microbubbles suspensions injectable into living organisms |
| 08/02/1995 | EP0457849B1 Electrotransport adhesive |
| 08/02/1995 | CN1105871A Chinese-medicinal preparation for treatment of burn and scald and preparation method |
| 08/02/1995 | CN1105859A Stable liquid preparation of complex vitamin for internal use |
| 08/02/1995 | CN1105857A Aqueous agent |
| 08/02/1995 | CN1105850A Medicinal plaster stroma |
| 08/02/1995 | CN1105849A Hard porous foam embolus and its manufacturing technology |
| 08/01/1995 | US5438072 Taxoid-based compositions |
| 08/01/1995 | US5438067 Medetomidine preparations for transdermal administration |
| 08/01/1995 | US5438044 Phospholipid composition |
| 08/01/1995 | US5438040 Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| 08/01/1995 | US5437874 Pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredients |
| 08/01/1995 | US5437873 Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
| 08/01/1995 | US5437872 Pharmaceutical compositions and a device for administering the same |
| 08/01/1995 | CA1336500C Opthalmic suspensions |
| 08/01/1995 | CA1336498C Pharmaceutical formulations for parenteral use |
| 08/01/1995 | CA1336497C Immunoconjugates for cancer diagnosis and therapy |
| 08/01/1995 | CA1336496C Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| 08/01/1995 | CA1336489C Molecular decoyants and methods of use thereof |
| 08/01/1995 | CA1336488C Dosage form having reduced abuse potential |
| 07/28/1995 | CA2141277A1 Method for preparing thioether conjugates |
| 07/27/1995 | WO1995019994A1 Method for solubilising antitumoral agents from the taxol family in an aqueous medium, and branched cyclodextrins therefor |
| 07/27/1995 | WO1995019792A1 Process for reducing the precipitation of difficultly soluble pharmaceutical actives |
| 07/27/1995 | WO1995019776A1 A method of treating glaucoma |
| 07/27/1995 | WO1995019775A1 A pharmaceutical composition with improved bio-availability of inositol phosphate |
| 07/27/1995 | WO1995019759A1 Process for solubilizing difficultly soluble pharmaceutical actives |
| 07/27/1995 | CA2181449A1 A method of treating glaucoma |
| 07/26/1995 | EP0664131A1 Kava extracts with optimal release |
| 07/26/1995 | EP0664120A1 Device for the vaginal administration of tamoxifen and its analogs |
| 07/26/1995 | EP0664119A2 Tape transdermal use easily detachable from the skin |
| 07/26/1995 | EP0664111A2 Biospecific emulsions |
| 07/26/1995 | EP0663951A1 Chitosan matrices for encapsulated cells |
| 07/26/1995 | EP0663840A1 Preparation of further diagnostic agents |
| 07/26/1995 | EP0663838A1 Stable, highly concentrated formulations of fluorescein derivatives |
| 07/26/1995 | EP0663837A1 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptide |
| 07/26/1995 | EP0663831A1 Transdermal azidothymidine |
| 07/26/1995 | EP0663829A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use |
| 07/26/1995 | EP0663816A1 Novel class of phosphocholine derivatives having antifungal activity |
| 07/26/1995 | EP0663815A1 Inhalation powders and method of manufacturing them |
| 07/26/1995 | EP0643584A4 Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material. |
| 07/26/1995 | EP0627911A4 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers. |
| 07/26/1995 | EP0527891B1 Biodegradable polyesters for sustained drug delivery |
| 07/26/1995 | EP0502092B1 Oral composition for the treatment of inflammatory bowel diseases |
| 07/25/1995 | US5436352 Metal radionuclide chelating compounds for improved chelation kinetics |
| 07/25/1995 | US5436241 Topical anti-inflammatory compositions containing piroxicam |
| 07/25/1995 | US5436221 Oligopeptides as antitumor agents |
| 07/25/1995 | CA2140813A1 Use of flavolignans as adjuvants in tumor therapy |
| 07/25/1995 | CA1336404C General cancer-associated scm-recognition factor, preparation and method of use |
| 07/25/1995 | CA1336403C Human relaxin formulation |
| 07/25/1995 | CA1336401C Intranasal administration of polypeptides in powdered form |
| 07/25/1995 | CA1336397C Methyl cellulose pharmaceutical composition |
| 07/20/1995 | WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides |
| 07/20/1995 | WO1995019430A1 Macroencapsulated secretory cells |
| 07/20/1995 | WO1995019376A1 Porous particle aggregate and method therefor |
| 07/20/1995 | WO1995019182A1 Somatic gene therapy to cells associated with fluid spaces |
| 07/20/1995 | WO1995019169A2 Treatment of platelet derived growth factor related disorders such as cancer using inhibitors of platelet derived growth factor receptor |
| 07/20/1995 | WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | WO1995019162A1 Estradiol penetration intensifier for transdermal administration |
| 07/20/1995 | WO1995017165A3 Tissue moisturizing and antimicrobial compositions |
| 07/20/1995 | WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/20/1995 | DE4400843A1 Antitumour and bio-surfactant ester(s) of D,L-alpha-liponic acid |
| 07/20/1995 | CA2181170A1 Somatic gene therapy to cells associated with fluid spaces |
| 07/20/1995 | CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | CA2180347A1 Anti-hepatitis b poly- and oligonucleotides |
| 07/19/1995 | EP0663212A2 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 07/19/1995 | EP0663013A1 Method for delivering nucleic acids into cells |
| 07/19/1995 | EP0662841A1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 07/19/1995 | EP0662840A1 Pharmaceutical compositions and methods for treating cold symptoms |
| 07/19/1995 | EP0662839A1 Vaccines and antigenic conjugates |
| 07/19/1995 | EP0662836A1 Germicidal detergent-iodine compositions having reduced detergent content |
| 07/19/1995 | EP0662835A1 New pharmaceutical formulations of spiramycine. |